2 resultsfor “Benefits of new ovarian cancer drug”
benefit from the new treatment – the first for hard-to-treat ovarian cancer in 20 years. There are nearly 7,750 cases of ovarian cancer in the UK each year. Patricia, from north London
new drug for resistant ovarian cancer to be approved for more than 20 years. Ovarian is the 18th most common type of cancer globally, affecting [more than 300,000 women](https://www.wcrf.org/preventing-cancer/cancer-statistics/ovarian-cancer-statistics/) a year